Preserving the Liver for Second-Line Treatment of Hepatocellular Carcinoma

被引：0
|
作者：
Lencioni, Riccardo [1 ,2 ]
机构：
[1] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Intervent Radiol,Intervent Radiol, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Intervent Radiol,Clin & Translat Res, Miami, FL 33136 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2016年 / 14卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6 / 8
页数：3
相关论文
共 50 条
  • [1] Regorafenib promising second-line treatment in hepatocellular carcinoma
    不详
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2016, 77 (08) : 446 - 446
  • [2] Cabozantinib as a second-line treatment option in hepatocellular carcinoma
    D'Angelo, Alberto
    Sobhani, Navid
    Bagby, Stefan
    Casadei-Gardini, Andrea
    Roviello, Giandomenico
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (06) : 623 - 629
  • [3] Advancements in second-line treatment research for hepatocellular carcinoma
    Sun, Ruirui
    Wu, Chenrui
    Gou, Yang
    Zhao, Yaowu
    Huang, Ping
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [4] How to Choose Second-Line Treatment for Hepatocellular Carcinoma
    Frenette, Catherine
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 726 - 729
  • [5] Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment
    Roviello, Giandomenico
    Casadei-Gardini, Andrea
    Nobili, Stefania
    Mini, Enrico
    Fancelli, Sara
    [J]. JOURNAL OF ONCOLOGY, 2020, 2020
  • [6] Targeted agents for second-line treatment of advanced hepatocellular carcinoma
    Personeni, Nicola
    Pressiani, Tiziana
    Bozzarelli, Silvia
    Rimassa, Lorenza
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 11 (10) : 788 - 803
  • [7] Targeted agents for second-line treatment of advanced hepatocellular carcinoma
    Nicola Personeni
    Tiziana Pressiani
    Silvia Bozzarelli
    Lorenza Rimassa
    [J]. World Journal of Gastrointestinal Oncology, 2019, (10) : 788 - 803
  • [8] Regorafenib as second-line therapy in hepatocellular carcinoma
    Duffy, Austin G.
    Greten, Tim F.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (03) : 141 - 142
  • [9] Second-Line Therapy for Patients With Hepatocellular Carcinoma
    Frenette, Catherine T.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 3 - 5
  • [10] Regorafenib as second-line therapy in hepatocellular carcinoma
    Austin G. Duffy
    Tim F. Greten
    [J]. Nature Reviews Gastroenterology & Hepatology, 2017, 14 : 141 - 142
12345